Ganzina F - Search Results

1

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia.

Lambertenghi-Deliliers G, Maiolo AT, Annaloro C, Cortelezzi A, Pogliani E, Ganzina F, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: ganzina f. Eur J Cancer Clin Oncol. 1987 Jul;23(7):1041-5. doi: 10.1016/0277-5379(87)90356-7. Eur J Cancer Clin Oncol. 1987. PMID: 3478198

2

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.

Mandelli F, Petti MC, Ardia A, Di Pietro N, Di Raimondo F, Ganzina F, Falconi E, Geraci E, Ladogana S, Latagliata R, et al. Mandelli F, et al. Among authors: ganzina f. Eur J Cancer. 1991;27(6):750-5. doi: 10.1016/0277-5379(91)90181-c. Eur J Cancer. 1991. PMID: 1829918 Clinical Trial.

3

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.

Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. Among authors: ganzina f. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Clinical Trial.

4

Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC).

Ardizzoni A, Pronzato P, Repetto L, De Palma M, Canobbio L, Gulisano M, Fusco V, Rosso R, Ganzina F. Ardizzoni A, et al. Among authors: ganzina f. Cancer Invest. 1988;6(4):409-11. doi: 10.3109/07357908809080069. Cancer Invest. 1988. PMID: 2846128

5

Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia.

Leone G, Pagano L, Marra R, Di Pietro N, Storti S, Sica S, D'Onofrio G, Ganzina F. Leone G, et al. Among authors: ganzina f. Haematologica. 1989 Jan-Feb;74(1):57-61. Haematologica. 1989. PMID: 2498185

6

A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumors.

Martoni A, Tomasi L, Farabegoli G, Giovannini M, Monetti N, Ganzina F, Pannuti F. Martoni A, et al. Among authors: ganzina f. Eur J Cancer Clin Oncol. 1984 Jan;20(1):11-7. doi: 10.1016/0277-5379(84)90028-2. Eur J Cancer Clin Oncol. 1984. PMID: 6581974

7

Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies.

Carella AM, Berman E, Maraone MP, Ganzina F. Carella AM, et al. Among authors: ganzina f. Haematologica. 1990 Mar-Apr;75(2):159-69. Haematologica. 1990. PMID: 2192943 Review.

8

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.

Ganzina F, Pacciarini MA, Di Pietro N. Ganzina F, et al. Invest New Drugs. 1986;4(1):85-105. doi: 10.1007/BF00172021. Invest New Drugs. 1986. PMID: 3516918 Review.

9

Phase II trial with oral idarubicin in advanced breast cancer.

Lopez M, Di Lauro L, Papaldo P, Lazzaro B, Ganzina F, Di Pietro N. Lopez M, et al. Among authors: ganzina f. Invest New Drugs. 1986;4(1):39-42. doi: 10.1007/BF00172014. Invest New Drugs. 1986. PMID: 3457780

10

Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.

Abate G, Comella P, Di Pietro N, Ganzina F, Pergola M, Silvestro P, Basso A, Salvatore M, Zarrilli D. Abate G, et al. Among authors: ganzina f. Tumori. 1987 Feb 28;73(1):43-7. doi: 10.1177/030089168707300108. Tumori. 1987. PMID: 3469805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters